[Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
作者信息
Abbou R, Mahoudeau D, Dubrisay J, Volteau M
出版信息
Sem Hop. 1965 Apr 20;41(19):1170-6.
PMID:4284191
Abstract
摘要
相似文献
1
[Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].精氨酸 - 甜菜碱 - 山梨醇联合疗法在代谢性肝病治疗中的意义
Sem Hop. 1965 Apr 20;41(19):1170-6.
2
[Therapeutic experience with the lipotropic hepatic drug Flacar in the internal medicine practice].[促脂性肝病药物弗拉卡尔在内科临床实践中的治疗经验]
ZFA (Stuttgart). 1976 Oct 31;52(30):1561-3.
3
[Betaine aspartate in the therapy of liver diseases].
Clin Ter. 1972 Mar 31;60(6):513-34.
4
[Therapeutical analysis of a sorbitol plus fentropilium compound on various clinical forms of liver diseases].[山梨醇加芬托溴铵复合物对各种临床类型肝病的治疗分析]
Hospital (Rio J). 1967 May;71(5):1403-12.
5
[Steatrope in digestive pathology].[消化病理学中的弹力纤维]
Bord Med. 1970 Oct;3(10):2513-4 passim.
6
7
[Treatment of liver diseases, especially of fatty liver with betaine citrate].[用柠檬酸甜菜碱治疗肝脏疾病，尤其是脂肪肝]
Ther Ggw. 1977 Nov;116(11):2113-24.
8
[Therapeutic activity of betaine aspartate].[天冬氨酸甜菜碱的治疗活性]
Clin Ter. 1972 May 15;61(3):227-36.
9
[On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].[关于口服精氨酸-1-磷酸葡萄糖治疗各种肝脏疾病]
Clin Ter. 1967 Dec 31;43(6):523-41.
10
[Lipotropic effect of betaine aspartate on experimental hepatic steatosis. Study using triolein-C14].[天冬氨酸甜菜碱对实验性肝脂肪变性的促脂解作用。使用三油酸甘油酯-C14的研究]
Therapie. 1966 May-Jun;21(3):719-31.
Zotero 插件